Fiche centre
University of Colorado Hospital
Aurora — United States
Essais liés4clinical trials
VilleAuroralocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07704918
Essais cliniques associés
4| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Evolocumab | Maladie coronarienne | Phase 4 | NCT05284747 | EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction | ACTIVE_NOT_RECRUITING |
| imiquimod | Cancer | Phase 3 | NCT02135419 | ANCHOR — Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions | COMPLETED |
| Ocrelizumab | SEP | Phase 3 | NCT02980042 | Safety of Switching From Rituximab to Ocrelizumab in MS Patients | COMPLETED |
| Statins (atorvastatin, rosuvastatin, simvastatin, or pravastatin), +/- ezetimibe, +/- PCSK9 inhibitor (alirocumab, evolocumab, inclisiran) | Maladie coronarienne | Non applicable | NCT07704918 | Aggressive Lipid Lowering Therapy in ICI-Treated Melanoma | RECRUITING |